These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Interconnection between polybuffer distribution and partition chromatography]. Brutko LI; Krutorogova EV Farmatsiia; 1972; 21(1):27-31. PubMed ID: 5031283 [No Abstract] [Full Text] [Related]
5. Instability of adenoviral vectors during transport and its implication for clinical studies. Nyberg-Hoffman C; Aguilar-Cordova E Nat Med; 1999 Aug; 5(8):955-7. PubMed ID: 10426323 [No Abstract] [Full Text] [Related]
6. Parenteral formulation. VI. Hydrolytic degradation of esters in parenteral solutions. Anschel J; Mollica JA; Lin KS Bull Parenter Drug Assoc; 1972; 26(6):271-89. PubMed ID: 4629105 [No Abstract] [Full Text] [Related]
8. The development and stability assessment of extemporaneous pediatric formulations of Accupril. Freed AL; Silbering SB; Kolodsick KJ; Rossi DT; Mahjour M; Kingsmill CA Int J Pharm; 2005 Nov; 304(1-2):135-44. PubMed ID: 16191467 [TBL] [Abstract][Full Text] [Related]
9. Novel pH-responsive polyphosphoester-based hydrogels with fast gelation. He J; Shao H; Zhang M; Ni P J Control Release; 2011 Nov; 152 Suppl 1():e232-3. PubMed ID: 22195877 [No Abstract] [Full Text] [Related]
10. [On the thin-layer chromatography study of the newly adapted parenterals at the Nagoya National Hospital]. Ninomiya E; Usami H; Yamada H; Morikawa A; Matsuyama K Iryo; 1969 Feb; 23(2):273-80. PubMed ID: 5803155 [No Abstract] [Full Text] [Related]
11. Novel pH-sensitive zwitterionic poly(amino acid) derivatives for drug delivery. Wang X; Wu G; He T; Wang Y; Wang Y; Fan Y; Gao H; Ma J J Control Release; 2011 Nov; 152 Suppl 1():e93-4. PubMed ID: 22195952 [No Abstract] [Full Text] [Related]
13. Preparation factors affecting the properties of polylactide nanoparticles: a factorial design study. Vandervoort J; Ludwig A Pharmazie; 2001 Jun; 56(6):484-8. PubMed ID: 11446170 [TBL] [Abstract][Full Text] [Related]
14. The effects of cosolvents on the action of pharmaceutical buffers. Rubino JT J Parenter Sci Technol; 1987; 41(2):45-9. PubMed ID: 3598819 [No Abstract] [Full Text] [Related]
15. [Physico-chemical characteristics of commercial thiazine dyes. 3. The effect of dye stuffs on hydrogen ion concentration in buffered and non-buffered aqueous solutions]. Clemens HJ; Toepfer K Acta Histochem; 1968; 31(1):135-45. PubMed ID: 4974890 [No Abstract] [Full Text] [Related]
16. [Effect of some factors on the stability of oxacillin solutions]. Novikevich AM Farm Zh; 1971; 26(1):59-61. PubMed ID: 5550215 [No Abstract] [Full Text] [Related]
17. Procedures important in the manufacture of ophthalmic preparations. Rosenberg SJ Bull Parenter Drug Assoc; 1970; 24(2):94-7. PubMed ID: 5439918 [No Abstract] [Full Text] [Related]
18. Evaluation of different buffers on plasmid DNA encapsulation into PLGA microparticles. Tse MT; Blatchford C; Oya Alpar H Int J Pharm; 2009 Mar; 370(1-2):33-40. PubMed ID: 19059325 [TBL] [Abstract][Full Text] [Related]
19. Stability of ondansetron hydrochloride in syrups compounded from tablets. Williams CL; Sanders PL; Laizure SC; Stevens RC; Fox JL; Hak LJ Am J Hosp Pharm; 1994 Mar; 51(6):806-9. PubMed ID: 8010321 [No Abstract] [Full Text] [Related]
20. [On the thermic stability of drug solutions]. Speiser P Pharm Acta Helv; 1968 Nov; 43(11):693-703. PubMed ID: 4888331 [No Abstract] [Full Text] [Related] [Next] [New Search]